These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36294873)

  • 1. Proposal for a Structured Outpatient Clinic for Dupilumab Treatment in Chronic Rhinosinusitis with Nasal Polyps in the First Year of Treatment.
    Torretta S; De Corso E; Nava N; Fraccaroli F; Ferrucci SM; Settimi S; Montuori C; Porru DP; Spanu C; D'Agostino G; Marzano AV; Pignataro L
    J Pers Med; 2022 Oct; 12(10):. PubMed ID: 36294873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Safety of Dupilumab Versus Omalizumab in Chronic Rhinosinusitis With Nasal Polyps and Asthma: EVEREST Trial Design.
    De Prado Gomez PharmD MSc L; Khan Mbbs Mph AH; Peters Md AT; Bachert Md PhD C; Wagenmann Md M; Heffler Md PhD E; Hopkins BMBCh C; Hellings Md PhD PW; Zhang PhD M; Xing PhD J; Rowe Md P; Jacob-Nara Md Mph DHSc JA
    Am J Rhinol Allergy; 2022 Nov; 36(6):788-795. PubMed ID: 35837739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials.
    Bachert C; Han JK; Desrosiers M; Hellings PW; Amin N; Lee SE; Mullol J; Greos LS; Bosso JV; Laidlaw TM; Cervin AU; Maspero JF; Hopkins C; Olze H; Canonica GW; Paggiaro P; Cho SH; Fokkens WJ; Fujieda S; Zhang M; Lu X; Fan C; Draikiwicz S; Kamat SA; Khan A; Pirozzi G; Patel N; Graham NMH; Ruddy M; Staudinger H; Weinreich D; Stahl N; Yancopoulos GD; Mannent LP
    Lancet; 2019 Nov; 394(10209):1638-1650. PubMed ID: 31543428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dupilumab-induced skin-associated side effects in patients with chronic rhinosinusitis with nasal polyposis.
    Chromy D; Bartosik T; Brkic FF; Quint T; Tu A; Eckl-Dorna J; Schneider S; Bangert C
    J Dermatol; 2023 Jan; 50(1):89-93. PubMed ID: 36177732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of dupilumab in patients with uncontrolled severe chronic rhinosinusitis with nasal polyps and a clinical diagnosis of NSAID-ERD: Results from two randomized placebo-controlled phase 3 trials.
    Mullol J; Laidlaw TM; Bachert C; Mannent LP; Canonica GW; Han JK; Maspero JF; Picado C; Daizadeh N; Ortiz B; Li Y; Ruddy M; Laws E; Amin N
    Allergy; 2022 Apr; 77(4):1231-1244. PubMed ID: 34459002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Olfactory Outcomes With Dupilumab in Chronic Rhinosinusitis With Nasal Polyps.
    Mullol J; Bachert C; Amin N; Desrosiers M; Hellings PW; Han JK; Jankowski R; Vodicka J; Gevaert P; Daizadeh N; Khan AH; Kamat S; Patel N; Graham NMH; Ruddy M; Staudinger H; Mannent LP
    J Allergy Clin Immunol Pract; 2022 Apr; 10(4):1086-1095.e5. PubMed ID: 34628065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measuring Nasal Patency and the Sense of Smell in CRSwNP Patients Treated with Dupilumab.
    Ottaviano G; De Corso E; Cantone E; Ciofalo A; Saccardo T; Bernardi R; Mairani E; Montuori C; Roccuzzo G; Soldati L; Randon B; Zampollo S; Chicco AD; Visconti F; Scarpa B; Nicolai P
    J Pers Med; 2023 Jan; 13(2):. PubMed ID: 36836468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of Dupilumab in the Treatment of Patients with Uncontrolled Severe CRSwNP: A "Real-Life" Observational Study in Naïve and Post-Surgical Patients.
    Ottaviano G; Saccardo T; Roccuzzo G; Bernardi R; Chicco AD; Pendolino AL; Scarpa B; Mairani E; Nicolai P
    J Pers Med; 2022 Sep; 12(9):. PubMed ID: 36143311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AROMA: real-world global registry of dupilumab for chronic rhinosinusitis with nasal polyps.
    Siddiqui S; Bachert C; Chaker AM; Han JK; Hellings PW; Peters AT; Heffler E; Kamat S; Zhang H; Nash S; Khan AH; De Prado Gomez L; Jacob-Nara JA; Rowe PJ; Deniz Y
    ERJ Open Res; 2022 Oct; 8(4):. PubMed ID: 36451848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dupilumab reduces opacification across all sinuses and related symptoms in patients with CRSwNP.
    Bachert C; Zinreich SJ; Hellings PW; Mullol J; Hamilos DL; Gevaert P; Naclerio RM; Amin N; Joish VN; Fan C; Zhang D; Staudinger H; Pirozzi G; Graham NMH; Khan A; Mannent LP
    Rhinology; 2020 Feb; 58(1):10-17. PubMed ID: 31671432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biologics for chronic rhinosinusitis.
    Chong LY; Piromchai P; Sharp S; Snidvongs K; Philpott C; Hopkins C; Burton MJ
    Cochrane Database Syst Rev; 2020 Feb; 2(2):CD013513. PubMed ID: 32102112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Canadian real-world study of access and clinical results using dupilumab for chronic rhinosinusitis with polyps.
    Kilty SJ; Lasso A
    J Otolaryngol Head Neck Surg; 2022 Apr; 51(1):17. PubMed ID: 35468866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of Dupilumab in the Treatment of Patients with Severe Uncontrolled CRSwNP: A "Real-Life" Observational Study in the First Year of Treatment.
    De Corso E; Settimi S; Montuori C; Corbò M; Passali GC; Porru DP; Lo Verde S; Spanu C; Penazzi D; Di Bella GA; Nucera E; Bonini M; Paludetti G; Galli J
    J Clin Med; 2022 May; 11(10):. PubMed ID: 35628815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of dupilumab treatment versus endoscopic sinus surgery for chronic rhinosinusitis with nasal polyps.
    Dharmarajan H; Falade O; Lee SE; Wang EW
    Int Forum Allergy Rhinol; 2022 Aug; 12(8):986-995. PubMed ID: 34919344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost Utility Analysis of Dupilumab Versus Endoscopic Sinus Surgery for Chronic Rhinosinusitis With Nasal Polyps.
    Scangas GA; Wu AW; Ting JY; Metson R; Walgama E; Shrime MG; Higgins TS
    Laryngoscope; 2021 Jan; 131(1):E26-E33. PubMed ID: 32243622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic Potential of Dupilumab in the Treatment of Chronic Rhinosinusitis with Nasal Polyps: Evidence to Date.
    Kim J; Naclerio R
    Ther Clin Risk Manag; 2020; 16():31-37. PubMed ID: 32158216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dupilumab effectiveness for the treatment of patients with concomitant atopic dermatitis and chronic rhinosinusitis with nasal polyposis.
    Napolitano M; Maffei M; Patruno C; Leone CA; Di Guida A; Potestio L; Scalvenzi M; Fabbrocini G
    Dermatol Ther; 2021 Nov; 34(6):e15120. PubMed ID: 34472171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biologics for chronic rhinosinusitis.
    Chong LY; Piromchai P; Sharp S; Snidvongs K; Webster KE; Philpott C; Hopkins C; Burton MJ
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013513. PubMed ID: 33710614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness and Safety Profile of Dupilumab in Chronic Rhinosinusitis with Nasal Polyps: Real-Life Data in Tertiary Care.
    Galletti C; Barbieri MA; Ciodaro F; Freni F; Galletti F; Spina E; Galletti B
    Pharmaceuticals (Basel); 2023 Apr; 16(4):. PubMed ID: 37111387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of dupilumab in patients with a history of prior sinus surgery for chronic rhinosinusitis with nasal polyps.
    Hopkins C; Wagenmann M; Bachert C; Desrosiers M; Han JK; Hellings PW; Lee SE; Msihid J; Radwan A; Rowe P; Amin N; Deniz Y; Ortiz B; Mannent LP; Rout R
    Int Forum Allergy Rhinol; 2021 Jul; 11(7):1087-1101. PubMed ID: 33611847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.